News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

April 27, 2026

The April 2026 News from ECOG-ACRIN blog is now available

April 8, 2026

ECOG-ACRIN vice chair Dr. Al Benson discusses the evolving role of first-line immunotherapy for advanced anal cancer, referencing the InterAACT-2 and EA2176 trials

April 8, 2026

Group co-chair Dr. Mitchell Schnall named a health system chief digital officer to know in 2026

March 30, 2026

The March 2026 News from ECOG-ACRIN blog is now available

March 24, 2026

ECOG-ACRIN study finds inferior survival among Black patients with AML, independent of cytogenetic risk

March 19, 2026

Press Release: ECOG-ACRIN completes enrollment for 600-patient clinical trial focused on frontline treatment for advanced melanoma

March 4, 2026

Press Release: ECOG-ACRIN Cancer Research Group announces the retirement of Robert Gray after 25 years as group statistician

March 2, 2026

Announcement: Group Statistician, Therapeutics, Leadership Transition

February 27, 2026

The February 2026 News from ECOG-ACRIN blog is now available

February 27, 2026

Attention medical and research trainees: Applications are now being accepted for the Edith Peterson Mitchell, MD, Health Equity Travel Scholarship to attend the Spring 2026 Group Meeting

February 27, 2026

Attention CRAs: Travel funds are available for the Spring 2026 Group Meeting (apply now)

February 27, 2026

Attention APPs: Travel funds are available for the Spring 2026 Group Meeting (apply now)

February 27, 2026

Attention radiation oncologists and trainees: Travel funds are available for the Spring 2026 Group Meeting (apply now)

February 13, 2026

The Winter 2026 advocacy blog Considering Clinical Trials is now available

February 9, 2026

Natasha Edwin, MD, community co-chair of the ECOG-ACRIN Myeloma Committee, highlights why patients in rural areas need access to quality clinical trials

February 3, 2026

ECOG-ACRIN legacy lung cancer studies E1594 and E5508 cited in ASCO Living Guideline 2026.3.0, therapy for stage 4 NSCLC without driver alterations

January 31, 2026

The January 2026 News from ECOG-ACRIN blog is now available

January 29, 2026

Press Release: New England Journal of Medicine publishes phase 3 PATINA (PrECOG PrE0111) trial data demonstrating a significant progression-free survival benefit with palbociclib in metastatic HR+, HER2+ breast cancer

January 21, 2026

ECOG-ACRIN study identifies high rates of vulnerability in AML patients aged 60 years or older

January 8, 2026

WATCH: Drs. Jen Specht and Heather Jacene discuss the FEATURE (EA1183) trial results…a game-changer for bone-dominant metastatic breast cancer

 
ECOG-ACRIN Cancer Research Group